Abstinence outcomes among women in reproductive health centers administered clinician or electronic brief interventions.


Journal

Journal of substance abuse treatment
ISSN: 1873-6483
Titre abrégé: J Subst Abuse Treat
Pays: United States
ID NLM: 8500909

Informations de publication

Date de publication:
06 2020
Historique:
received: 02 12 2019
revised: 07 02 2020
accepted: 20 02 2020
entrez: 4 5 2020
pubmed: 4 5 2020
medline: 29 7 2021
Statut: ppublish

Résumé

Treatment of substance use in women seeking reproductive healthcare is crucial for the health of both women and their offspring. Although abstinence from all substance use during pregnancy is optimal, it is difficult to achieve. This secondary analysis reports abstinence outcomes from a randomized clinical trial of screening, brief intervention, and referral to treatment (SBIRT) for substance use among women seeking reproductive healthcare services. Women who screened positive for substance use were randomly assigned to either clinician-administered SBIRT, an electronically-administered brief intervention (e-SBIRT), or an enhanced usual care condition. At a 6-month follow-up assessment, compared to enhanced usual care, the clinician-administered SBIRT increased 1-month point prevalence of abstinence from the primary substance by 7.7%, and e-SBIRT increased abstinence by 12.8%. Both brief interventions were more useful than enhanced usual care and could increase substance use abstinence rates among women in reproductive healthcare clinics. The electronic brief intervention is particularly attractive given that it appears as efficacious as, but requires fewer resources than, clinician-delivered brief interventions.

Identifiants

pubmed: 32359666
pii: S0740-5472(19)30657-9
doi: 10.1016/j.jsat.2020.02.012
pmc: PMC8372233
mid: NIHMS1731974
pii:
doi:

Types de publication

Journal Article Randomized Controlled Trial Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

107995

Subventions

Organisme : NIAAA NIH HHS
ID : R01 AA026596
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA027194
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA034243
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest Dr. Yonkers discloses royalties from Up To Date; Dr. Ondersma discloses that he is part-owner of Interva, Inc., which markets the intervention authoring tool that was used to develop the electronic intervention for this study.

Références

Drug Alcohol Depend. 2019 Dec 1;205:107590
pubmed: 31600616
Drug Alcohol Depend. 2005 Jan 7;77(1):49-59
pubmed: 15607841
Am J Prev Med. 2016 Nov;51(5):801-811
pubmed: 27745678
Arch Intern Med. 2005 May 9;165(9):986-95
pubmed: 15883236
J Psychopharmacol. 2010 Sep;24(9):1403-10
pubmed: 19939863
Br J Addict. 1991 Sep;86(9):1119-27
pubmed: 1932883
J Subst Abuse Treat. 2018 Jan;84:30-41
pubmed: 29195591
Am J Obstet Gynecol. 2018 Mar;218(3):322.e1-322.e12
pubmed: 29247636
Alcohol Res. 2014;36(1):63-79
pubmed: 26259001
Am J Public Health. 2003 Apr;93(4):635-41
pubmed: 12660210
J Nerv Ment Dis. 1992 Feb;180(2):101-10
pubmed: 1737971
J Clin Psychiatry. 1998;59 Suppl 20:22-33;quiz 34-57
pubmed: 9881538
Cochrane Database Syst Rev. 2008 Apr 16;(2):CD000165
pubmed: 18425860
J Subst Abuse Treat. 2015 Jan;48(1):37-42
pubmed: 25151440
Am J Psychiatry. 2017 Oct 1;174(10):954-962
pubmed: 28595490
Subst Abus. 2007;28(3):7-30
pubmed: 18077300
Drug Alcohol Depend. 2008 Jul 1;96(1-2):37-48
pubmed: 18328638
Addiction. 2010 Aug;105(8):1381-90
pubmed: 20528806
Addiction. 2014 Jul;109(7):1091-8
pubmed: 24520906
J Subst Abuse Treat. 2005 Jun;28(4):305-12
pubmed: 15925264
J Subst Abuse Treat. 2019 Apr;99:1-7
pubmed: 30797381
Alcohol Clin Exp Res. 2015 Jul;39(7):1219-26
pubmed: 26010235
Subst Abus. 2015;36(1):13-20
pubmed: 24266770
Ann Intern Med. 2004 Apr 6;140(7):557-68
pubmed: 15068985
Addiction. 2017 Feb;112 Suppl 2:54-64
pubmed: 28074568
Addiction. 2014 Aug;109(8):1287-94
pubmed: 24661345
J Subst Abuse Treat. 2014 Jan;46(1):52-9
pubmed: 24051077
Drug Alcohol Depend. 2019 Nov 1;204:107565
pubmed: 31751868
Alcohol Res Health. 2006;29(1):55-62
pubmed: 16767855
PLoS One. 2014 Jun 17;9(6):e99912
pubmed: 24937483
Addiction. 2008 Jun;103(6):1039-47
pubmed: 18373724
J Consult Clin Psychol. 2000 Feb;68(1):134-44
pubmed: 10710848
Am J Prev Med. 2007 Mar;32(3):231-8
pubmed: 17236741
J Stud Alcohol. 2006 Jul;67(4):568-78
pubmed: 16736077
Health Informatics J. 2019 Sep;25(3):771-787
pubmed: 28764600
Drug Alcohol Rev. 2003 Jun;22(2):169-73
pubmed: 12850903
J Stud Alcohol Drugs. 2009 May;70(3):426-35
pubmed: 19371494
BMJ. 2002 Oct 19;325(7369):870
pubmed: 12386040
Drug Alcohol Depend. 2015 May 1;150:147-55
pubmed: 25772437
Health Aff (Millwood). 2016 Jun 1;35(6):1017-21
pubmed: 27269017
Addiction. 2016 Jul;111(7):1144-50
pubmed: 26216706
Addiction. 2019 Sep;114(9):1659-1669
pubmed: 31111591

Auteurs

Kimberly A Yonkers (KA)

Department of Psychiatry, Yale School of Medicine, 300 George Street, New Haven, CT 06511, USA; Department of Obstetrics, Gynecology and Reproductive Sciences, Yale School of Medicine, 333 Cedar Street, New Haven, CT 06510, USA; Department of Epidemiology and Public Health, Yale School of Medicine, 60 College Street, New Haven, CT 06510, USA. Electronic address: Kimberly.Yonkers@yale.edu.

Jason I Dailey (JI)

Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD 20814, USA. Electronic address: Jason.I.Dailey.mil@mail.mil.

Kathryn Gilstad-Hayden (K)

Department of Psychiatry, Yale School of Medicine, 300 George Street, New Haven, CT 06511, USA. Electronic address: Kathryn.Gilstad-Hayden@yale.edu.

Steven J Ondersma (SJ)

Wayne State University, Merrill Palmer Skillman Institute, 71 E. Ferry Ave, Detroit, MI 48202, USA. Electronic address: s.ondersma@wayne.edu.

Ariadna Forray (A)

Department of Psychiatry, Yale School of Medicine, 300 George Street, New Haven, CT 06511, USA. Electronic address: Ariadna.Forray@yale.edu.

Todd A Olmstead (TA)

University of Texas at Austin, PO Box Y, Austin, TX 78713, USA. Electronic address: TOlmstead@austin.utexas.edu.

Steve Martino (S)

Department of Psychiatry, Yale School of Medicine, 300 George Street, New Haven, CT 06511, USA; VA Connecticut Healthcare System, 950 Campbell Avenue, West Haven, CT 06516, USA. Electronic address: Steve.Martino@yale.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH